We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Catalent Inc
19 own
17 watching
Current Price
$45.66
$-0.13
(-0.28%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
8,225.8M
52-Week High
81.72
52-Week Low
31.45
Average Volume
0.77M
Dividend Yield
--
P/E Ratio
38.4575
Market Capitalization8,225.8M52-Week High81.7252-Week Low31.45Average Volume0.77MDividend Yield--P/E Ratio38.4575What does the Catalent Inc do?
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products worldwide. It operates through three segments: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services. The Softgel Technologies segment provides formulation, development, and manufacturing services for softgels, which are used in a range of customer products, including prescription drugs, over-the-counter medications, dietary supplements, and unit-dose cosmetics. Its principal softgel technologies include traditional softgel capsules, and Vegicaps and OptiShell capsules. The Drug Delivery Solutions segment formulates, develops, and manufactures prescription, and consumer and animal health products using proprietary technologies, including OptiMelt, OptiPact, OptiForm, and Zydis, as well as other proprietary and conventional drug delivery technologies, such as prefilled syringes; manufactures blow-fill seal unit dose, including ADVASEPT technology; develops biologic cell line, including GPEx and SMARTag technologies; and provides analytical and bioanalytical development, and testing services, as well as offers respiratory products formulation and manufacturing, micronization and particle engineering, and regulatory consulting services. The Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials for customer required patient kits. This segment also offers FastChain demand-led clinical supply services; clinical e-solutions and informatics; and comparator sourcing services. The company serves pharmaceutical and biotechnology companies; and consumer health companies, as well as companies in other healthcare market segments, such as animal health and medical devices, and companies in industries, including cosmetics. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.
Read More
How much money does Catalent Inc make?
News & Events about Catalent Inc.
Business Wire
3 months ago
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc. (NYSE: CTLT) on behalf of long-term stockholders following a class action complaint that was filed against Catalent on February 28, 2023 with a Class...
PR Newswire
3 months ago
Thinking about buying stock in T Rowe Price, Ross Stores, Davita, Catalent, or Finch Therapeutics? Thinking about buying stock in T Rowe Price, Ross Stores, Davita, Catalent, or Finch Therapeutics? PR Newswire NEW YORK, June 13, 2023 NEW YORK, June 13, 2023 /PRNewswire/ -- InvestorsObserver issues...
Globe Newswire
4 months ago
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Alico, Inc. (NASDAQ: ALCO) Johnson Fistel, LLP is investigating potential claims on behalf of Alico, Inc. ("Alico" or the "Company") (NASDAQ: ALCO) against certain of its officers and directors. If you are a current, long-term shareholder of Alico holding ...
Globe Newswire
5 months ago
SAN FRANCISCO, April 25, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Catalent, Inc. (NYSE: CTLT) investors who suffered substantial losses submit your losses now. Class Period: Aug. 30, 2021 Oct. 31, 2022Lead Plaintiff Deadline: Apr. 25, 2023Visit: https://www.hbsslaw.com/investor-fraud/CTLT ...
Business Wire
5 months ago
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 25, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Catalent, Inc. (Catalent or the Company) (NYSE: CTLT) securities between August 30, 2021 and October 31, 2022...
Frequently Asked Questions
Frequently Asked Questions
What is Catalent Inc share price today?
Can Indians buy Catalent Inc shares?
How can I buy Catalent Inc shares from India?
Can Fractional shares of Catalent Inc be purchased?
What are the documents required to start investing in Catalent Inc stocks?
What is today’s traded volume of Catalent Inc?
What is today’s market capitalisation of Catalent Inc?
What is the 52-Week High and Low Range of Catalent Inc?
What percentage is Catalent Inc down from its 52-Week High?
What percentage is Catalent Inc up from its 52-Week Low?
Current Price
$45.66
$-0.13
(-0.28%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.